Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03920631
Title Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas (MicroBLITZ)
Acronym MicroBLITZ
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Duke University
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.